3P

3W Partners

North America, Missouri, United States, Saint Louis

Description

3W Partners, a Greater China and cross-border focused private equity firm

Investor Profile

3W Partners has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series Unknown, Series E rounds (top funding stages).
  • Majority of deals are located in United States, China.
  • Strong thematic focus on Biotechnology, Life Science, Health Care.

Stage Focus

  • Series C (33%)
  • Series Unknown (33%)
  • Series E (33%)

Country Focus

  • United States (67%)
  • China (33%)

Industry Focus

  • Biotechnology
  • Life Science
  • Health Care
  • Genetics
  • Therapeutics
  • Chemical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does 3W Partners frequently co-invest with?

Ditch Plains Capital Management LP
North America, New York, United States, Manhasset
Co-Investments: 1
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 1
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 1
MRL Ventures Fund
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Blue Pool Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
GlaxoSmithKline
Europe, England, United Kingdom, London
Co-Investments: 1
Biomatics Capital Partners
North America, Washington, United States, Seattle
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by 3W Partners?

LifeMine Therapeutics

Cambridge, Massachusetts, United States

LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.

BiotechnologyGeneticsLife ScienceTherapeutics
Series CMar 23, 2022
Amount Raised: $175,000,000
CANbridge Pharmaceuticals

Beijing, Beijing, China

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .

BiotechnologyHealth CarePharmaceutical
Series EDec 1, 2020
Amount Raised: $43,000,000
Twist Bioscience

San Francisco, California, United States

Twist Bioscience is a synthetic DNA production for specialty chemical compounds and drug development.

BiotechnologyChemicalHealth CareLife Science
Series UnknownJun 14, 2017
Amount Raised: $27,000,000